Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
Mes dernières consult.
Most popular
Rapport
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Celgene Corporation
Develops human pharmaceuticals and agrochemicals

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases.

Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax.

Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Number of employees : 7 132 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Innovative Therapies9,256104%11,229102.8% +21.32%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States5,60463%7,01064.2% +25.08%
Europe2,62429.5%3,04627.9% +16.08%
All Other1,02811.5%1,17310.7% +14.17%
Managers
NameAgeSinceTitle
Mark Alles582004Chief Executive Officer & Director
Scott Andrew Smith552008President & Chief Operating Officer
Robert Hugin621999Executive Chairman
Peter N. Kellogg, MBA612014Chief Financial Officer & Executive Vice President
Joseph S. Camardo, MD62-Senior Vice President-Global Medical Affairs
Rupert J. Vessey, PhD522015President-Research & Early Development
Gilla Kaplan, PhD701998Independent Director
Michael D. Casey712002Lead Independent Director
James J. Loughlin, CPA742007Independent Director
Ernest Mario, PhD792007Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 964,350,672 780,422,968 80.9% 182,000,000 18.9% 80.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 53,527,210 6.84%
BlackRock Fund Advisors 39,211,518 5.01%
SSgA Funds Management, Inc. 32,410,705 4.14%
Jennison Associates LLC 13,415,734 1.71%
T. Rowe Price Associates, Inc. 12,373,682 1.58%
Fidelity Management & Research Co. 12,225,169 1.56%
Edgewood Management LLC 10,457,953 1.34%
Northern Trust Investments, Inc. 10,447,120 1.34%
Wellington Management Co. LLP 8,799,099 1.12%
Columbia Management Investment Advisers LLC 8,739,421 1.12%
Holdings
NameEquities%Valuation
Juno Therapeutics Inc (JUNO) 11,109,1609.72%498,356,918 USD
Agios Pharmaceuticals Inc (AGIO) 5,242,70410.9%349,950,492 USD
BEIGENE LTD COM 32,746,41610.4%260,532,778 USD
Acceleron Pharma Inc (XLRN) 6,118,47913.9%228,341,636 USD
Crispr Therapeutics AG (CRSP) 4,834,98011.9%86,401,093 USD
Epizyme Inc (EPZM) 3,674,6405.42%70,001,892 USD
Oncomed Pharmaceuticals Inc (OMED) 2,970,5887.89%13,427,058 USD
Zymeworks Inc (ZYME) 1,539,4836.08%12,285,074 USD
Alliqua Biomedical Inc (ALQA) 8,046,10016.1%2,936,827 USD
GlobeImmune Inc (GBIM) 600,67010.4%300,335 USD
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP100, SP500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  CELG:US
- Reuters Code :  CELG.O
- Datastream Code :  
Company contact information
Celgene Corporation
86 avenue Morris
US-NJ 07901 Summit, New Jersey
États-Unis (les)

Phone : +1 908 673 9000
Fax : +1
Internet : http://www.celgene.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
CELGENE CORPORATION18.51%107 315
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372
MERCK AND COMPANY7.88%173 214
AMGEN27.41%135 924
SANOFI9.90%125 891
BAYER19.94%115 989
BRISTOL-MYERS SQUIBB COMPANY9.00%104 463
GLAXOSMITHKLINE-1.82%99 651
NOVO NORDISK A/S22.22%98 848
ABBOTT LABORATORIES45.20%96 897
ELI LILLY AND COMPANY16.56%94 388
ASTRAZENECA16.64%86 419
ALLERGAN PLC-10.89%62 565
SHIRE-20.59%44 568
TAKEDA PHARMACEUTICAL CO LTD30.38%44 097
ASTELLAS PHARMA INC-7.07%27 649
JIANGSU HENGRUI MEDICINE CO LTD40.24%27 044
CHUGAI PHARMACEUTICAL CO LTD54.69%25 693
Connections : Celgene Corporation
Darden School Foundation
University of Virginia Darden School of Business
Princeton University
Atlantic Health System, Inc.
Chilton Memorial Hospital
Desmond Tutu Hiv Foundation
Receptos, Inc.
Rutgers University Foundation
PharmAkea, Inc.
Family Promise
Choose New Jersey
Sidecar Therapeutics, Inc.
HealthCare Institute of New Jersey
Bill & Melinda Gates Foundation Trust
Biotechnology Innovation Organization
Eyenovia, Inc.
Orbus Therapeutics, Inc.
Mali Health Organizing Project
Gilda's Club New York City
American College of Physicians Foundation
Gladstone Foundation (CA)
Rosemont College
Taxis Pharmaceuticals, Inc.
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem